Supplier · Peer benchmark
Peer comparison
How Alexion Rare Disease part of Astra Zeneca stacks up against suppliers competing for the same workloads — based on overlap with its 1 signature CPV code over the last 24 months.
Value band:
/
CohortAlexion Rare Disease part of Astra Zeneca(You)Dr Reddy's Laboratories (UK) LtdJanssen-Cilag LtdThornton and Ross LtdACCORD-UK LTDAbbVie Ltd
iAuto-picked from 1 signature CPV code · last 24 months overlap
Metric | DR Dr Reddy's Laboratories (UK) Ltd Peer · rank #1 | JA Janssen-Cilag Ltd Peer · rank #2 | TA Thornton and Ross Ltd Peer · rank #3 | AC ACCORD-UK LTD Peer · rank #4 | AB AbbVie Ltd Peer · rank #5 | AR Alexion Rare Disease part of Astra Zeneca (You) · target supplier |
|---|---|---|---|---|---|---|
01ActivityVolume, scale, freshness | ||||||
| 12-month contractedAward value, last 12m | £56.3m | £56.3m | £56.3m | £56.3m | £47.0m | — |
| Framework headroomPer-supplier share of framework ceilings | — | — | — | — | — | — |
| Total awarded (lifetime)All time, all contracts | £207.7m | £457.1m | £230.1m | £287.4m | £461.1m | — |
| Contracts won (12m)Distinct awards last year | 8 | 4 | 2 | 12 | 3 | — |
How to read a target cell
The target column carries a delta — value compared to the peer median for that row. Direction-of-good varies by metric, so deltas are neutral.
Peer cell£499m(peer median £255m)
→
Target cell£11.7m(−97% vs median)
Money:
£N.Nm, £Nk, £N.NbnPercent: 42% · pp delta: (+12pp)Day delta: (−149 days) · missing: —